Regentis Biomaterials Ltd. SEC filings RGNT
Regentis Biomaterials Ltd. has 93 filings in SEC EDGAR's recent list, going back to Mar 29, 2022. Its latest annual report, Form 20-F, was filed on Feb 24, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 13, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F/A | Amended annual report (foreign issuer) | Feb 27, 2026 | Dec 31, 2025 |
| 20-F | Annual report (foreign issuer) | Feb 24, 2026 | Dec 31, 2025 |
Showing 2 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- RGNT (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Or Akiva
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1912966
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- STERIS plc STE
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.